Cosmos Health Inc. (COSM) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cosmos Health Inc. (COSM) has a cash flow conversion efficiency ratio of -0.249x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.60 Million) by net assets ($18.42 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Cosmos Health Inc. stock valuation for the company's overall valuation and market capitalisation.
Cosmos Health Inc. - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Cosmos Health Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cosmos Health Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cosmos Health Inc. ranked by their cash flow conversion efficiency. Explore earnings quality score of Cosmos Health Inc. to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TIALIS ESSENTIAL IT PLC
F:U6M
|
N/A |
|
Americas Car-Mart Inc
NASDAQ:CRMT
|
0.213x |
|
BTC Digital Ltd.
NASDAQ:BTCT
|
-0.007x |
|
Hang Feng Technology Innovation Co., Ltd.
NASDAQ:FOFO
|
N/A |
|
A1 Investments & Resources Ltd
AU:AYI
|
0.118x |
|
Metro Bank PLC
LSE:MTRO
|
0.195x |
|
MDB Capital Holdings, LLC Class A common
NASDAQ:MDBH
|
-0.052x |
|
B.V. Delftsch Aardewerkfabriek "De Porceleyne Fles Anno 1653"
AS:PORF
|
0.002x |
Annual Cash Flow Conversion Efficiency for Cosmos Health Inc. (2010–2025)
The table below shows the annual cash flow conversion efficiency of Cosmos Health Inc. from 2010 to 2025. View COSM stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $18.42 Million | $-8.45 Million | -0.458x | -45.76% |
| 2024-12-31 | $24.53 Million | $-7.72 Million | -0.315x | +27.49% |
| 2023-12-31 | $36.04 Million | $-15.64 Million | -0.434x | -15.69% |
| 2022-12-31 | $39.66 Million | $-14.87 Million | -0.375x | +76.86% |
| 2021-12-31 | $4.38 Million | $-7.10 Million | -1.621x | -158.63% |
| 2020-12-31 | $-4.16 Million | $-11.50 Million | 2.764x | +272.92% |
| 2019-12-31 | $-6.46 Million | $-4.79 Million | 0.741x | +58.10% |
| 2018-12-31 | $-3.32 Million | $-1.56 Million | 0.469x | -83.80% |
| 2017-12-31 | $-3.03 Million | $-8.76 Million | 2.893x | +138.52% |
| 2016-12-31 | $-1.75 Million | $-2.13 Million | 1.213x | +204.48% |
| 2015-12-31 | $-1.25 Million | $-497.09K | 0.398x | -66.58% |
| 2014-12-31 | $5.47 Million | $6.53 Million | 1.192x | +107.70% |
| 2013-12-31 | $-53.68K | $831.40K | -15.487x | -67992.51% |
| 2012-12-31 | $-1.36K | $31.00 | -0.023x | -100.12% |
| 2011-12-31 | $-4.76K | $-87.29K | 18.330x | +360.38% |
| 2010-12-31 | $-17.48K | $-69.60K | 3.982x | -- |
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more